These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6925461)

  • 1. Enhancement of delayed cutaneous hypersensitivity in untreated cancer patients given a short-term oral treatment with C 1821.
    Lang JM; Giron C; Aleksijevic A; Marchiani C; Zalisz R; Oberling F
    Cancer Immunol Immunother; 1982; 14(1):59-60. PubMed ID: 6925461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulating effects of a short-term oral treatment with C 1821 in untreated cancer patients: a controlled study.
    Lang JM; Aleksijevic A; Giron C; Levy S; Falkenrodt A; Mayer S; Stoclet JC; Oberling F
    Adv Exp Med Biol; 1983; 166():171-80. PubMed ID: 6316764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of delayed cutaneous hypersensitivity by oral administration of RU 41740 (Biostim) in lymphoma patients--a randomized double blind multicentric trial.
    Lang JM; Gastaut JA; Sotto JJ; Troncy J; Marchiani C
    Int J Immunopharmacol; 1986; 8(7):687-90. PubMed ID: 3536765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas.
    Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
    Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phytohemagglutinin skin tests in cancer patients.
    Zuckerman KS; LoBuglio AF
    Cancer; 1977 Jun; 39(6):2355-61. PubMed ID: 266970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin tests in childhood lymphoma and neuroblastoma.
    Gasparini M; Bardare M; Fossati Bellani F
    Tumori; 1976; 62(4):429-34. PubMed ID: 1020049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune function of successfully treated lymphoma patients.
    King GW; Yanes B; Hurtubise PE; Balcerzak SP; LoBuglio AF
    J Clin Invest; 1976 Jun; 57(6):1451-60. PubMed ID: 932190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invited discussion: relationship of titers of Epstein-Barr virus to cell-mediated immunity in patients with Hodgkin's disease.
    Levine PH; Reisher JI
    Natl Cancer Inst Monogr; 1973 May; 36():85-7. PubMed ID: 4355354
    [No Abstract]   [Full Text] [Related]  

  • 9. Cutaneous delayed-type hypersensitivity responsiveness in lepromatous and borderline lepromatous leprosy patients as determined by MULTITEST CMI.
    Walsh DS; Villahermosa LG; Balagon MV; Abalos RM; Fajardo TT; Tan EV; Cellona RV; Walsh GP
    Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):518-26. PubMed ID: 10774662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed hypersensitivity responses of cancer patients to recall antigens using a new "Multitest" applicator.
    Reuben JM; Hersh EM
    Ann Allergy; 1984 Nov; 53(5):390-4. PubMed ID: 6594072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo and in vitro assays of cellular immunity to human tumor antigens.
    Herberman RB
    Fed Proc; 1973 Feb; 32(2):160-4. PubMed ID: 4120197
    [No Abstract]   [Full Text] [Related]  

  • 12. Delayed cutaneous hypersensitivity testing in untreated Hodgkin's disease using a standardized new device.
    Lang JM; Giron C; de Leon J; Oberling F
    Biomedicine; 1980 May; 33(3):62-4. PubMed ID: 7448324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed hypersensitivity in chronic lymphocytic leukemia.
    Block JB; Haynes HA; Thompson WL; Neiman PE
    J Natl Cancer Inst; 1969 Jun; 42(6):973-80. PubMed ID: 5797552
    [No Abstract]   [Full Text] [Related]  

  • 14. Delayed hypersensitivity in cancer patients: cutaneous and in vitro lymphocyte response to specific antigens.
    Nelson HS
    J Natl Cancer Inst; 1969 May; 42(5):765-70. PubMed ID: 5797546
    [No Abstract]   [Full Text] [Related]  

  • 15. Delayed-type hypersensitivity and immunoglobulin levels in the course of chemotherapy of advanced malignant neoplasms.
    Singer Z; Salwa J
    Arch Immunol Ther Exp (Warsz); 1973; 21(2):239-47. PubMed ID: 4581915
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunologic evaluation of patients with cancer by delayed hypersensitivity reactions.
    Burdick JF; Wells SA; Herberman RB
    Surg Gynecol Obstet; 1975 Nov; 141(5):779-94. PubMed ID: 128144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune deficiency in Hodgkin and non-Hodgkin lymphoma.
    El-Haddad SI; El-Ashmawy S; Hassan W; George E; Ali FM; Sharaf MA; Mahfouz M
    Biomedicine; 1980 Oct; 32(3):128-33. PubMed ID: 7448322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin reactions to phytohemagglutinin in the healthy elderly subject and in the immunodeficient subject.
    Krc I; Matousková I; Patchová D
    Arch Intern Med; 1983 May; 143(5):1074. PubMed ID: 6679224
    [No Abstract]   [Full Text] [Related]  

  • 19. Antigen solubilized from human solid tumours: lymphocyte stimulation and cutaneous delayed hypersensitivity.
    Mavligit GM; Ambus U; Gutterman JU; Hersh EM; McBride CM
    Nat New Biol; 1973 Jun; 243(127):188-90. PubMed ID: 4514633
    [No Abstract]   [Full Text] [Related]  

  • 20. Delayed hypersensitivity in Hodgkin's disease. A study of 103 untreated patients.
    Young RC; Corder MP; Haynes HA; DeVita VT
    Am J Med; 1972 Jan; 52(1):63-72. PubMed ID: 5058359
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.